Report : A-Z HCD items in Formulary 05/03/2021 20:21:14
[
Back
]
Section
Status
Black Triangle
Name
08.02
Formulary
Acalabrutinib Calquence
®
08.02.03
Restricted Use
Blinatumomab Blincyto
®
08.02
Formulary
Brigatinib Alunbrig
®
11.08.02
Restricted Use
Brolucizumab Beovu
®
05.01.02.01
Restricted Use
Cefiderocol Fetcroja
®
08.02.03
Formulary
Daratumumab Darzalex®
04.07.04.02
Restricted Use
Fremanezumab Ajovy
®
08.02
Formulary
Gilteritinib Xospata
®
06.01.01.01
Restricted Use
Insulin Lispro Lyumjev
®
08.02.03
Restricted Use
Isatuximab Sarclisa
®
08.01
Non Formulary
Lorlatinib Lorviqua®
08.02
Formulary
Lorlatinib Lorviqua®
08.02
Formulary
Niraparib Zejula®
08.02
Formulary
Osimertinib Tagrisso®
09.02.01.01
Restricted Use
Patiromer Veltassa®
08.02.03
Restricted Use
Polatuzumab vedotin Polivy
®
07.01
Formulary
Prasterone Intrarosa®
08.02
Formulary
Rucaparib Rubraca®
04.09.01
Restricted Use
Safinamide Xadago
®
09.02.01.01
Restricted Use
Sodium Zirconium Cyclosilicate
06.06.01
Formulary
Teriparatide Terrosa®
08.02
Formulary
Venetoclax Venclyxto
®
05.03.04
Formulary
Zanamivir Injection Dectova
The Mid Yorkshire Hospitals